Dengue Fever Testing Market Size, Industry Share, Analysis, Report and Forecast 2022-27
The global Dengue Fever Testing market size reached US$ 522.6 million in 2021. By 2027, it will reach a value of US$ 726.34 million, growing at a rate of 5.40% (2022- 2027).
SHERIDAN, WYOMING, USA, Sept. 9, 2022 /EINPresswire.com/ — The latest research study “Dengue Testing Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027 by IMARC Group, concludes that the Global Dengue Testing Market reached a value of US$522.6 million in 2021. Looking ahead, IMARC Group expects the market to reach a value of US$726.34 million by 2027, growing at a CAGR of 5.40% in 2022-2027.
Dengue, or unrestrained fever, refers to a viral infection transmitted by the bite of an infected Aedes aegypti mosquito. Some of its common symptoms include joint and muscle pain, vomiting, difficulty breathing, cold clammy skin, headache, eye pain, high fever, nausea, fatigue, skin rash and slight bleeding from gums and nose. Dengue testing involves RT-PCR, enzyme immunoassay (ELISA) and dengue IgG/IgM rapid tests. It is carried out by doctors to identify the different serotypes of the dengue virus using a blood sample. As a result, dengue fever screening tests are gaining popularity around the world to examine people with signs and symptoms of dengue disease.
Request a free sample PDF copy for more detailed market information: https://www.imarcgroup.com/dengue-testing-market/requestsample
Note: We regularly track the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Dengue Fever Testing Market Trends and Drivers:
The global dengue fever testing market is mainly driven by the increase in dengue fever cases due to increase in mosquito breeding sites and global warming. Additionally, there has been an increasing adoption of dengue testing as it helps in early detection of severe cases, clinical trials, outbreak management, academic research, vaccine development, surveillance efforts, case confirmation and differential diagnosis with other infectious diseases.
Additionally, the growing need for accurate and efficient diagnosis of dengue fever has increased the demand for products. In addition, poor sanitation and waste management techniques in densely populated areas due to lack of public awareness and poor living conditions are another major growth factor.
Moreover, the governments of many countries are organizing awareness campaigns which in turn have catalyzed the growth of the market. Other factors including technological advancements in the healthcare sector, ongoing research and development (R&D) activities, and rapid urbanization are also expected to propel the growth of the market.
Analysis and segmentation of the global dengue fever testing market 2022-2027:
The competitive landscape of the market has been studied in the report with the detailed profiles of the major players operating in the market.
Abbott Laboratories, Abnova Corporation, CerTest Biotec SL, DiaSorin SpA, F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.
The report has segmented the market based on region, test type, and end user.
Breakdown by type of test:
• ELISA-based assays
• Tests based on RT-PCR
• Dengue fever IgG/IgM rapid test
Breakdown by end user:
• Diagnostic centers
Breakdown by region:
• North America: (United States, Canada)
• Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, others)
• Middle East and Africa
Ask the analyst to customize and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/dengue-testing-market
If you want the latest primary and secondary data (2022-2027) with cost module, business strategy, distribution channel, etc. Click request a free sample report, the published report will be emailed to you in PDF format within 24-48 hours of receipt. full payment.
Main highlights of the report:
• Market performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s five forces analysis
• Market drivers and success factors
• SWOT analysis
• Value chain
• Complete mapping of the competitive landscape
If you need specific information that is not currently covered in the report, we can provide it to you as part of the customization.
Browse IMARC Group Other Latest Research Reports:
Neonatal Ventilator Market Report 2022-2027: https://www.imarcgroup.com/neonatal-ventilator-market
Cancer Cachexia Market 2022-2027: https://www.imarcgroup.com/cancer-cachexia-market
Pediatric Interventional Cardiology Market Report 2022-2027: https://www.imarcgroup.com/pediatric-interventional-cardiology-market
Radiology Information System Market Size 2022-2027: https://www.imarcgroup.com/radiology-information-system-market
Pharmacovigilance and Drug Safety Software Market Report 2022-2027: https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
Email: [email protected]
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Services Private Limited
write to us here